Author:
Avila Amy M.,Bebenek Ilona,Bonzo Jessica A.,Bourcier Todd,Davis Bruno Karen L.,Carlson David B.,Dubinion John,Elayan Ikram,Harrouk Wafa,Lee Shwu-Luan,Mendrick Donna L.,Merrill Jill C.,Peretz Jackye,Place Emily,Saulnier Muriel,Wange Ronald L.,Yao Jia,Zhao Dong,Brown Paul C.
Subject
Toxicology,General Medicine
Reference96 articles.
1. 21CFR312, Code of Federal Regulations. Title 21: Food and Drugs, Subchapter D: Drugs for Human Use, Part 312: Investigational New Drug Application.
2. 21CFR314, Code of Federal Regulations. Title 21: Food and Drugs, Subchapter D: Drugs for Human Use, Part 314: Applications for FDA Approval to Market a New Drug.
3. 21CFR601, Code of Federal Regulations. Title 21: Food and Drugs, Subchapter F: Biologics, Part 601: Licensing.
4. Blood-brain barrier structure and function and the challenges for CNS drug delivery;Abbott;J. Inherit. Metab. Dis.,2013
5. Gastrointestinal safety pharmacology in drug discovery and development;Al-Saffar;Handb. Exp. Pharmacol.,2015
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献